Last edition
News about
Cipla Unit Recalls One Lot of Medication in US Due to Seal Integrity Issue
Drug major Cipla said its subsidiary is voluntarily recalling one lot of medication in the US due to seal integrity issues.
Indoco Remedies Receives Tentative ANDA Approval from USFDA for Canagliflozin Tablets
This product will be manufactured by Indoco Remedies Limited, at their manufacturing facility located at Goa (Plant-I) in India.
Under the terms of the Agreement, Coya has granted Dr. Reddy’s an exclusive license to commercialize COYA 302, a proprietary co-pack kit containing combination of low dose IL-2 and CTLA-4 Ig (abatacept) in the United States, Canada, the European Union and the United Kingdom for ALS.
Lupin Receives Approval from US FDA for Varenicline Tablets
Varenicline Tablets, 0.5 mg and 1 mg are indicated for use as an aid to smoking cessation treatment.
Sun Pharma Subsidiary Signs Licensing Agreement with Biopharma Company Aclaris Therapeutics
As per the licensing agreement, Aclaris has granted exclusive rights to Sun Pharma under certain patents for the use of deuruxolitinib, Sun Pharma's JAK inhibitor, or other isotopic forms of ruxolitinib, to treat alopecia areata (AA) or androgenetic alopecia (AGA).
AIT Worldwide Logistics Acquires British Pharma Shipment Specialist
Supply chain solutions provider AIT Worldwide Logistics has acquired the British pharmaceutical freight forwarder Mach II Shipping Ltd., the company said.
MAHE's Centre for cGMP, Manipal Bags India Pharma Awards 2023 for Excellence in Quality Assurance
MAHE Manipal achieved a significant milestone of being awarded the prestigious INDIA PHARMA AWARDS 2023 on Day 1 of CPHI-PMEC India.
Recipharm Announces Collaboration with Oz-UK
The pMDIs will utilise valves and actuators from Recipharm’s Bespak brand, and a new generation of low global warming potential (GWP) propellants.
Akums Drugs and Pharma Acquires New Facility in Baddi
This facility, the 12th under Akums and the second in Baddi, will enhance the company's tablet manufacturing capacity, as per the release.
Vibcare Healthcare Opens Pharma Manufacturing Facility in Panchkula, Haryana
The company informed, spanning over five acres, the facility adheres to international standards, including EU GMP, PIC/S and UKMHRA GMP.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy